In another study performed on HNSCC cells in vitro, apigenin treatment inhibited survival and induced apotosis by reducing ligand-induced phosphorylation of EGFR and ErbB2 and modulating their downstream signaling [55]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.